TR200401847T4 - Makrolit antibiyotikler. - Google Patents

Makrolit antibiyotikler.

Info

Publication number
TR200401847T4
TR200401847T4 TR2004/01847T TR200401847T TR200401847T4 TR 200401847 T4 TR200401847 T4 TR 200401847T4 TR 2004/01847 T TR2004/01847 T TR 2004/01847T TR 200401847 T TR200401847 T TR 200401847T TR 200401847 T4 TR200401847 T4 TR 200401847T4
Authority
TR
Turkey
Prior art keywords
compounds
formula
methods
infections
macrolide antibiotics
Prior art date
Application number
TR2004/01847T
Other languages
English (en)
Inventor
Kaneko Takushi
Thomas Mcmillen William
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200401847T4 publication Critical patent/TR200401847T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bu bulus, asagidaki formüle ait bilesiklerle ve bunlarin farmasötik açidan kabul gören tuzlari, ön ilaçlari ve solvatlari ile ilgilidir; buradaki X, Y, R1, R2, R3, R4 ve R6, burada tanimlandigi gibidir. Formül I bilesikleri, çesitli bakteriyel ve protozoal enfeksiyonlari ve bu enfeksiyonlar ile baglantili bozukluklari tedavi etmek için kullanilabilen antibakteriyel ve antiprotozoal ajanlardir. Bulus ayrica formül I bilesikleri içeren farmasötik kompozisyonlarla, bilesiklerin yapilma metotlariyla ve bilesikler uygulanarak bakteriyel ve protozoal enfeksiyonlarin tedavi edilmesine yönelik metotlarla da ilgilidir.
TR2004/01847T 2000-06-30 2001-06-21 Makrolit antibiyotikler. TR200401847T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21523700P 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
TR200401847T4 true TR200401847T4 (tr) 2004-09-21

Family

ID=22802202

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01847T TR200401847T4 (tr) 2000-06-30 2001-06-21 Makrolit antibiyotikler.

Country Status (12)

Country Link
US (1) US6809080B2 (tr)
EP (1) EP1167376B1 (tr)
JP (1) JP3587380B2 (tr)
AT (1) ATE271062T1 (tr)
BR (1) BR0102623A (tr)
CA (1) CA2351829C (tr)
DE (1) DE60104240T2 (tr)
DK (1) DK1167376T3 (tr)
ES (1) ES2222966T3 (tr)
MX (1) MXPA01006751A (tr)
PT (1) PT1167376E (tr)
TR (1) TR200401847T4 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100245A (et) * 1998-11-03 2002-10-15 Pfizer Products Inc. Uued makroliidsed antibiootikumid
DK1147121T3 (da) 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
EP1483277A4 (en) 2002-02-15 2007-10-03 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
SI1836211T1 (sl) 2004-12-21 2010-04-30 Pfizer Prod Inc Makrolidi

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CO4990960A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
FR2777282B1 (fr) 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EE200100245A (et) * 1998-11-03 2002-10-15 Pfizer Products Inc. Uued makroliidsed antibiootikumid
FR2786188B1 (fr) 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DK1147121T3 (da) 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
ES2306674T3 (es) 1999-12-02 2008-11-16 Abbott Laboratories Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
EP1114826A3 (en) 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides

Also Published As

Publication number Publication date
DK1167376T3 (da) 2004-10-25
US6809080B2 (en) 2004-10-26
DE60104240T2 (de) 2005-08-04
US20020052328A1 (en) 2002-05-02
DE60104240D1 (de) 2004-08-19
JP3587380B2 (ja) 2004-11-10
JP2002265488A (ja) 2002-09-18
CA2351829A1 (en) 2001-12-30
BR0102623A (pt) 2002-02-13
MXPA01006751A (es) 2002-10-23
PT1167376E (pt) 2004-09-30
CA2351829C (en) 2006-01-17
EP1167376A1 (en) 2002-01-02
ES2222966T3 (es) 2005-02-16
EP1167376B1 (en) 2004-07-14
ATE271062T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DK1132392T3 (da) Ketolid-antibiotika
EA200100623A1 (ru) Кетолидные антибиотики
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
BG105543A (en) Novel macrolide antibiotics
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
ATE271062T1 (de) Makrolid-antibiotika
YU66900A (sh) Derivati higromicina a
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
YU64300A (sh) Derivati 2"-deoksi higromicina
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
EA200201167A1 (ru) Производные гигромицина а для лечения бактериальных и протозойных инфекций
AP2002002492A0 (en) Hygromycin a prodrugs.
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina